Cells were
isolated either from whole blood treated with CPDA-1 anticoagulant or from
platelet-depleted buffy coats, both obtained from normal healthy donors
tested negative for HIV-I, HIV-II, hepatitis B and syphilis, the ratio male\
female being approximately 2:1.
Erythrocytes were
removed by the treatment of whole blood or buffy coats with Dextran T500
(Pharmacia, Biotech) (1), plasma being used as a source of platelets in the
former case. White blood cells were concentrated by the centrifugation, and
mononuclear cells (MN) (B- and T-lymphocytes and monocytes) and
polymorphonuclear cells (PMN) (mostly neutrophils) were separated in a
preformed Percoll (Pharmacia) gradient (2).
Platelets were isolated
as described (3, 4).
The purity of MN, PMN
and platelets was more than 98% for each cell population, as it was
evaluated by staining fixed smears of freshly isolated cells with
hematoxylin.
Resting CD14+ (monocytes),
CD4+ (T helper \ inducer cells), CD8+ (T supressor \ cytotoxic cells) and
CD19+ (B lymphocytes) were positively selected from MN cell suspensions by
immunomagnetic separation using Dynabeads M-450 according to Dynal
recommendations ( 5). The purity of CD4+, CD8+ and CD19+ was not less than
95% for each cell population, as it was evaluated by immunostaining fixed
smears of positively isolated target cells, detached from Dynabeads using
the corresponding DETACHaBEAD systems ( 5). The immunostaining was
performed by a routine procedure using primary antibodies to CD4, CD8 and
CD19 ( Becton & Dickinson), Vectastatin ABC Kit ( Vector Lab.) and DAB (
Sigma) as a substrate according to the standard Vectastatin ABC Kit
protocol.
Cells
Activation
Activation of MN cells,
B- and T-lymphocytes was performed as recommended (6, 7 and 8) with some
modifications. Isolated cells were suspended in RPMI 1640 containing 10%
fetal calf serum ( Gibco), 100 U\ml penicillin, 100 mg\ml streptomycin, 2
mM glutamine, vitamins, non-essential aminoacids and sodium pyruvate ( High
Clone) , the cell density was adjusted up to 1´ 10 6 cell \ ml,
and the cultures were incubated at 37oC in a humidified
atmosphere of 5% CO2 in air.
Activation of lymphocytes was
estimated on the basis of morphological criteria ( blast morphology,
mitoses) and expression of the two activation markers, CD25 ( IL-2 receptor)
and CD71 ( transferrin receptor), established immunocytochemically as
pointed above.
In the case of MN cells
the culture medium was supplemented with 2 ml\ml PWM (pokeweed mitogen,
Gibco) and 5 mg\ml Con A (concanavalin A, ICN ), and the cultures were
incubated for 3 days. The activated cells were collected, washed and used
for isolation of total RNA. The immunocytochemical analysis showed that the
preparations of activated MN cells contained 51±12% CD4+, 42±14% CD8+,
6±4% CD19+ and 60±17% CD25+.
Activated CD4+ cells (
CD4+ blasts) were isolated in a discontinuous Percoll gradient after CD8+,
CD19+ and partially CD14+ - depleted MN cells had been incubated with 5
mg\ml Con A for 3-4 days. The preparations of activated CD4+ contained 90±4%
CD4+, 2±1% CD8+, 94±3% CD25+ . There were no observed CD19+ cells.
Activated CD8+ cells
were positively selected by immunomagnetic separation from CD14+ and CD4+ -
depleted MN cells incubated with 5 mg\ml PHA (phytohemagglutinin, Pan Eco,
Russia ) for 3 days. The preparations of CD8+ activated cells contained
95±3% CD8+, 1±1% CD4+, 2±1% CD19+ and 88±1% CD25+.
Activated CD19+ cells
were positevely selected by immunomagnetic separation from CD14+ and CD8+
- depleted MN cells incubated with 2ml\ml PWM for 4 days. The preparations
of activated CD19+ cells contained 92±2% CD19+, 4±2% CD4+ and 87±3% CD71+.
There were no observed CD8+ cells.
References
1.
Scandinavian
Journal of Immunology, 1976, Supplement n 5 : Lymphocytes. Isolation,
fractionation and characterization. Edited by J.B.Natvig, P.Perlmann & H.
Wigzell
2.
Percoll.
Methodology and applications. Pharmacia Fine Chemicals
3.
A.V.Mazurov et
al. Thrombos. Haemostas. 1991, 66, 494-499
4.
A.I.Kuznetsov
et al. Eur.J. Haematol. 1992, 49, 113-118
5.
Cell
separation and protein purification. Technical Handbook, Second Edition.
Dynal
6.
Lymphocytes. A
practical approach, 1987. Edited by G.G.B.Klaus. IRL Press
7.
Fundamental
Immunology, 1984. Editor W.E.Paul. Raven Press
8.
G.Sieber et
al. Blut, 1980, 41, 81-92
RNA Purification
Total RNA was isolated
using Qiagen RNeasy Midi Kit followed by DNAase treatment ( RNAase-free
DNAase, Epicentre ) with subsequent cleaning up RNA preparations using
repeated Qiagen RNeasy Midi Kit procedure. All preparations had the value of
28S/18S ribosomal RNAs ratio no less than 1.6 . QC was made using
Agilent BioAnalyzer. Typical QC results are shown
here.
PolyA+RNA was
isolated from Total RNA using two repeated steps of oligo (dT)
chromatography, and was considered to be passed QC if no genomic DNA was
detected after 40 cycles of Real-Time PCR using MHC Class I primers.
Figure Typical results on glyoxal
electrophoresis of isolated RNA preparations.
|
L1.
RNA Ladder
1. PolyA+
RNA, A549
2. PolyA+ RNA, HeLa
3. PolyA+ RNA, G361
4. Total RNA, A549
5. Total RNA, HeLa
6. Total RNA, G361
L2. 1 kb RNA Ladder |
|